BriaCell Therapeutics Corp. (BCTX)Healthcare | Biotechnology | West Vancouver, Canada | NasdaqCM
4.43 USD
+0.11
(2.546%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 4.51 +0.08 (1.734%) ⇧ (April 17, 2026, 7:51 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 2:44 p.m. EDT
BriaCell Therapeutics Corp. (BCTX) presents a highly volatile and uncertain investment profile. The recent price history shows significant fluctuations, with the stock trading below its 50-day average and experiencing a sharp decline over the last few weeks. The stock's negative forward PE and trailing EPS suggest poor profitability, and the high beta indicates it is more sensitive to market movements than the broader market. The recent news headlines highlight both positive developments, such as the addition of a license and a credit lifeline, and negative events like a stock plunge following a $30 million offering. These mixed signals suggest a lack of clear momentum. Additionally, the absence of dividends indicates that this stock is not suitable for income-focused investors. Given the lack of a clear upward trend, the high volatility, and the negative fundamentals, this stock is not a favorable short-term or long-term investment at this time. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.154242 |
| AutoARIMA | 0.154247 |
| AutoTheta | 0.163296 |
| MSTL | 0.195268 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.69 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.666 |
| Excess Kurtosis | -0.44 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 32,119,656 |
| Forward P/E | -11.36 |
| Beta | 1.63 |
| Website | https://briacell.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8942721 |
| Address1 | Bellevue Centre |
| Address2 | Suite 300 235 -15th Street |
| All Time High | 1,563.518 |
| All Time Low | 3.5 |
| Ask | 5.64 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 133,650 |
| Average Daily Volume3 Month | 264,775 |
| Average Volume | 264,775 |
| Average Volume10Days | 133,650 |
| Beta | 1.626 |
| Bid | 3.22 |
| Bid Size | 2 |
| Book Value | 4.264 |
| City | West Vancouver |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Canada |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.43 |
| Current Ratio | 10.102 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 4.54 |
| Day Low | 4.36 |
| Display Name | BriaCell Therapeutics |
| Dividend Date | 1,577,923,200 |
| Earnings Timestamp End | 1,750,104,000 |
| Earnings Timestamp Start | 1,749,758,400 |
| Ebitda | -30,630,110 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.049 |
| Enterprise Value | 1,513,398 |
| Eps Forward | -0.39 |
| Eps Trailing Twelve Months | -14.42 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 604 921 1898 |
| Fifty Day Average | 4.152 |
| Fifty Day Average Change | 0.27799988 |
| Fifty Day Average Change Percent | 0.066955656 |
| Fifty Two Week Change Percent | -89.42721 |
| Fifty Two Week High | 98.2 |
| Fifty Two Week High Change | -93.77 |
| Fifty Two Week High Change Percent | -0.954888 |
| Fifty Two Week Low | 3.6 |
| Fifty Two Week Low Change | 0.8299999 |
| Fifty Two Week Low Change Percent | 0.23055553 |
| Fifty Two Week Range | 3.6 - 98.2 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,331,731,800,000 |
| Float Shares | 6,410,301 |
| Forward Eps | -0.39 |
| Forward P E | -11.358974 |
| Free Cashflow | -20,493,214 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0060799997 |
| Held Percent Institutions | 0.01153 |
| Implied Shares Outstanding | 7,250,487 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-02-24 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,753,920,000 |
| Last Split Date | 1,756,080,000 |
| Last Split Factor | 1:10 |
| Long Business Summary | BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada. |
| Long Name | BriaCell Therapeutics Corp. |
| Market | us_market |
| Market Cap | 32,119,656 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_262266102 |
| Most Recent Quarter | 1,769,817,600 |
| Net Income To Common | -29,637,656 |
| Next Fiscal Year End | 1,785,456,000 |
| Non Diluted Market Cap | 32,226,432 |
| Open | 4.36 |
| Operating Cashflow | -30,967,316 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 604 921 1810 |
| Post Market Change | 0.07680035 |
| Post Market Change Percent | 1.7336422 |
| Post Market Price | 4.5068 |
| Post Market Time | 1,776,469,874 |
| Previous Close | 4.32 |
| Price Hint | 4 |
| Price To Book | 1.0389305 |
| Profit Margins | 0.0 |
| Quick Ratio | 9.387 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.11 |
| Regular Market Change Percent | 2.54629 |
| Regular Market Day High | 4.54 |
| Regular Market Day Low | 4.36 |
| Regular Market Day Range | 4.36 - 4.54 |
| Regular Market Open | 4.36 |
| Regular Market Previous Close | 4.32 |
| Regular Market Price | 4.43 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 113,716 |
| Return On Assets | -0.89438003 |
| Return On Equity | -1.7920799 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 7,250,487 |
| Shares Percent Shares Out | 0.039 |
| Shares Short | 282,815 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 103,944 |
| Short Name | BriaCell Therapeutics Corp. |
| Short Percent Of Float | 0.039 |
| Short Ratio | 1.19 |
| Source Interval | 15 |
| State | BC |
| Symbol | BCTX |
| Total Cash | 29,903,628 |
| Total Cash Per Share | 4.124 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -14.42 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.2787 |
| Two Hundred Day Average Change | -3.8487 |
| Two Hundred Day Average Change Percent | -0.46489185 |
| Type Disp | Equity |
| Volume | 113,716 |
| Website | https://briacell.com |
| Zip | V7T 2X1 |